Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 17, 2025 07:00 ET | Source: Regeneron Pharmaceuticals, Inc.

Regeneron Announces Positive Phase 3 Trial in Adults with Ultra-Rare Genetic Disorder Fibrodysplasia Ossificans Progressiva (FOP), Demonstrating that Garetosmab Prevents Greater than 99% of Abnormal Bone Formation

FOP is a disease in which muscles, tendons and ligaments are progressively replaced by bone, leading to eventual incapacitation Garetosmab is the first and only treatment to demonstrate a...
October 22, 2013 12:44 ET | Source: abas-USA

abas-USA Announces New On-Site Training Facility

STERLING, VA--(Marketwired - Oct 22, 2013) - abas-USA is pleased to announce they will be moving and expanding their East Coast headquarters in November. The new facility will accommodate future...